Skip to main content
. 2017 Apr 28;22(5):707–715. doi: 10.1007/s12192-017-0797-6

Table 2.

Relative affinities for association of PfHsp70-1 with its interactors in the presence of nucleotide and/or PMB

Analyte, ligand Nucleotide K D (M) χ 2 Reference
PfHsp70-1, PfHsp70-z ATP 2.41 (± 0.2) e−08 1.86 Zininga et al. 2016
ADP 1.21 (± 0.1) e−06 2.12 Zininga et al. 2016
NN 5.98 (± 0.5) e−05 3.32 Zininga et al. 2016
PMB 2.50 (± 0.8) e−04* 2.65 This study
PfHsp70-1NBD, PfHsp70-z ATP 2.12 (± 0.2) e−09 2.65 Zininga et al. 2016
ADP 9.86 (± 0.9) e−08 6.52 Zininga et al. 2016
NN 1.57 (± 0.6) e−08 2.44 Zininga et al. 2016
PMB 8.41 (± 0.7) e−05** 4.72 This study
PfHsp70-1, PfHop ATP 1.13 (± 0.5) e−08 2.15 Zininga et al. 2015b
ADP 1.72 (± 0.5) e−09 2.30 Zininga et al. 2015b
NN 1.91 (± 0.01) e−09 2.17 Zininga et al. 2015b
PMB 1.60 (± 0.08) e−06** 1.22 This study

The interaction kinetics represented by the equilibrium constant (K D) were determined by SPR analysis alternating the status of PfHsp70-z/PfHop and PfHsp70-1/PfHsp70-1NBD as ligand and analyte, respectively. The ligand was the respective immobilized protein on the GLC chip surface and the analyte was the respective protein injected at a flow rate of 50 μl/min. Data were analyzed by using readings obtained for the running buffer (in the presence of nucleotides, but in the absence of protein analyte) as baseline (Fig. 4). Data are represented as mean plus/minus standard deviation. Chi-square (χ 2) values represent the Langmuir curve fitting residuals. Statistical analysis was conducted using one-way ANOVA. *p < 0.005, **p < 0.001 represents statistically significant differences in affinities noted under the variable experimental conditions